Table 2.
Study of factors associated with recurrence. Bi-variable analyses between host factors, primary cyst and treatment used with recurrence
| Patients with recurrences | n/N (%) | OR (IC95%) | p-value* |
|---|---|---|---|
| Host factors | |||
| Age ≤ 59 years | 17/124 (13.7) | 1.6 (0.6–4.0) | 0.244 |
| Male sex | 18/133 (13.5) | 1.7 (0.6–4.3) | 0.243 |
| Patients from rural areas | 17/148 (11.5) | 0.9 (0.4–2.4) | 0.982 |
| Professional activity-agriculture/livestock | 2/31 (6.5) | 0.4 (0.1–2.1) | 0.340 |
| Contact with animals | 4/60 (6.7) | 0.4 (0.1–1.4) | 0.166 |
| Immigrants | 0/6 (0.0) | – | – |
| Comorbidity | 7/73 (9.6) | 0.7 (0.2–1.8-) | 0.526 |
| Cyst primary factors | |||
| Complicated | 9/88 (10.2) | 0.8 (0.3–1.9) | 0.622 |
| Cyst size (≥7 cm) | 16/122 (13.1) | 1.4 (0.6–3.4) | 0.405 |
| Cyst location | |||
| Liver Lung Others/disseminated |
19/193 (9.8) 0/12 (0.0) 7/31 (22.6) |
0.3 (0.1–0.9) – 2.7 (1.1–7.1) |
0.028* – 0.037* |
| No. of cysts (≥2) | 11/80 (13.8) | 1.4 (0.6–3.2) | 0.432 |
| WHO classification CE1 CE2 CE3 CE4 CE5 |
19/193 (9.8) 0/10 (0.0) 8/59 (13.6) 4/32 (12.5) 2/30 (6.7) 5/62 (8.1) |
0.587 | |
| Factors associated to treatment | |||
| Combinated treatment (Antihelminths & surgical) | 20/141 (14.2) | 2.3 (1.4–6.5) | 0.094 |
| Surgical technics | 5/76 (6.6) | ||
| Surgical treatment complications | 7/38 (18.4) | 2.0 (0.7–5.2) | 0.142 |
*p-value of the test: Total patients with treatment with curative intention-follow-up & Recurrences. Statistical significance level of 5% (p < 0.05)